DalsnaFinance › IPOs › Phathom Pharmaceuticals Inc › IPO
Phathom Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on October 25, 2019, pricing at $19.00 a share.
| Ticker | PHAT |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 25, 2019 |
| Offering price | $19.00 |
| Shares offered | 9,563,157 |
| Total raised | $182M |
Phathom Pharmaceuticals, Inc. sold 9,563,157 shares at $19.00 each on NASDAQ. Multiplied out, that is $181.7 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $182 million total recorded for the deal.
Phathom Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Phathom Pharmaceuticals, Inc.. This page is general information, not investment advice.